ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 117 filers reported holding ANAPTYSBIO INC in Q1 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $542,396 | -12.3% | 30,201 | -0.6% | 0.00% | 0.0% |
| Q2 2023 | $618,173 | +84813.9% | 30,392 | -9.2% | 0.00% | 0.0% |
| Q1 2023 | $728 | -29.1% | 33,474 | +1.0% | 0.00% | 0.0% |
| Q4 2022 | $1,027 | -99.9% | 33,131 | +1.5% | 0.00% | 0.0% |
| Q3 2022 | $832,000 | +34.0% | 32,632 | +6.7% | 0.00% | 0.0% |
| Q2 2022 | $621,000 | -2.4% | 30,597 | +19.0% | 0.00% | 0.0% |
| Q1 2022 | $636,000 | -39.7% | 25,702 | -15.3% | 0.00% | 0.0% |
| Q4 2021 | $1,054,000 | +26.8% | 30,337 | -1.0% | 0.00% | 0.0% |
| Q3 2021 | $831,000 | +6.1% | 30,647 | +1.5% | 0.00% | 0.0% |
| Q2 2021 | $783,000 | -1.6% | 30,187 | -18.3% | 0.00% | 0.0% |
| Q1 2021 | $796,000 | -5.4% | 36,939 | -5.6% | 0.00% | 0.0% |
| Q4 2020 | $841,000 | +59.0% | 39,124 | +9.2% | 0.00% | 0.0% |
| Q3 2020 | $529,000 | -43.2% | 35,837 | -14.0% | 0.00% | -50.0% |
| Q2 2020 | $931,000 | +94.4% | 41,656 | +22.8% | 0.00% | +100.0% |
| Q1 2020 | $479,000 | -11.5% | 33,925 | +1.9% | 0.00% | 0.0% |
| Q4 2019 | $541,000 | -53.2% | 33,303 | +0.9% | 0.00% | -50.0% |
| Q3 2019 | $1,155,000 | -37.3% | 33,015 | +1.1% | 0.00% | -33.3% |
| Q2 2019 | $1,843,000 | -10.0% | 32,664 | +16.5% | 0.00% | -25.0% |
| Q1 2019 | $2,048,000 | +13.9% | 28,041 | -0.5% | 0.00% | 0.0% |
| Q4 2018 | $1,798,000 | +4.9% | 28,181 | +64.0% | 0.00% | +33.3% |
| Q3 2018 | $1,714,000 | +32.3% | 17,180 | -5.8% | 0.00% | 0.0% |
| Q2 2018 | $1,296,000 | -27.0% | 18,242 | +6.9% | 0.00% | -25.0% |
| Q1 2018 | $1,776,000 | +9.8% | 17,062 | +6.2% | 0.00% | +33.3% |
| Q4 2017 | $1,618,000 | +342.1% | 16,063 | +53.3% | 0.00% | +200.0% |
| Q3 2017 | $366,000 | – | 10,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |